Europe – Treatments and vaccines for COVID-19: medicines under evaluation

The European Medicines Agency (EMA) is evaluating potential COVID-19 treatments and vaccines to enable promising medicines to reach patients in the European Union (EU) as soon as possible.

EMA is assessing all applications for COVID-19 medicines under the minimum timeframe necessary to allow a thorough evaluation of the medicine’s benefits and risks, in accordance with its usual standards for qualitysafety and effectiveness